62
Pharma & HealthcareBuy
DSP Healthcare
DSP · Direct–Growth · rank #6 of 18 by Smart Score
Trailing returns
1 Year
10.1%
+9.6% vs index
3 Years
23.0%
+10.8% vs index
5 Years
16.1%
+4.1% vs index
Since launch
23.2%
Year-by-year performance
2021
+25.1%-5.5% vs index
2022
-6.5%-10.3% vs index
2023
+36.8%+10.3% vs index
2024
+42.6%+27.0% vs index
2025
-4.5%-12.2% vs index
2026
+13.1%+14.8% vs index
Why this score
DSP Healthcare scores 62/100 — #6 of 18 Pharma & Healthcare fund (Buy). It stands out for 5y return and expense ratio — beating 72% of peers on 5y return. It has no major weak spot vs the category.
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return16.05% · 72nd percentile in category
Expense ratio0.65% · 92nd percentile in category
Fund size3514.02 Cr · 81st percentile in category
Sortino ratio1.82 · 66th percentile in category
3Y return22.99% · 45th percentile in category
Sharpe ratio1.12 · 56th percentile in category